The Vaccination Portal was opened for people aged 43-44

At the same time, vaccinations of persons falling within essential services, as approved by a special committee set up for this purpose, are progressing rapidly.

742ce8b35cd4ac9678092bed08a75f23 ΠΥΛΗ ΕΜΒΟΛΙΑΣΜΟΥ

Proceeding with the implementation of the National Vaccination Plan against COVID-19, and increasing the rate of vaccinations in order to achieve coverage and immunity of a significant percentage of the population as soon as possible, the Ministry of Health announces that on Monday, April 26, from 7:30 a.m. to 8 p.m., will have priority for arranging vaccination appointments people aged 43 and 44 only. The vaccinations will be carried out in Vaccination Centers that operate in all Provinces. Next week the Vaccination Portal will also open for other age groups and more details will be given at a later stage.

At the same time, vaccinations of people falling into essential services, as approved by a special committee set up for this purpose.

It is also noted that the process of expression of interest by them is in progress Personal Doctors who wish to be given AstraZeneca vaccines for the vaccination of their beneficiaries aged 30 and over.

It is recalled that, in view of the entry into force of tomorrow measures decided by the Council of MinistersIt is not necessary to send a text message for the purpose of going to a Vaccination Center, provided that the necessary evidence is provided (form, text message, Vaccination Card) for control purposes. In addition, for as many people have completed their vaccination regimen with any of the available licensed vaccines and a period of 14 days has elapsed since the last dose was taken, the following applies:

  • Mandatory self-restraint is not required in case these individuals are considered close case contact.
  • Exempted from the obligation to weekly check with fast test.

By April 23, they were done a total of 236,265 vaccinations (26,8 doses per 100 inhabitants), of which 176,082 (20%) related to its administration 1th dose and 60,183 (6,8%) related to the administration of both doses.